- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Foster City Today
By the People, for the People
BCGM Wealth Management LLC Invests in Gilead Sciences
Institutional investor acquires new position in biopharmaceutical company
Mar. 21, 2026 at 7:43am
Got story updates? Submit your updates here. ›
BCGM Wealth Management LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 11,746 shares of the biopharmaceutical company's stock, valued at approximately $1,442,000.
Why it matters
Gilead Sciences is a major biopharmaceutical company focused on developing antiviral therapies, oncology treatments, and other innovative medicines. New investments from institutional investors like BCGM Wealth Management can signal confidence in the company's future growth and product pipeline.
The details
BCGM Wealth Management LLC acquired the new position in Gilead Sciences during the fourth quarter of 2026. The 11,746 shares purchased were valued at around $1.44 million. Other hedge funds and institutional investors have also recently modified their holdings of Gilead Sciences, with some increasing and others decreasing their positions in the stock.
- The new position was acquired in the 4th quarter of 2026.
The players
BCGM Wealth Management LLC
An institutional investor that acquired a new position in Gilead Sciences, Inc.
Gilead Sciences, Inc.
A biopharmaceutical company focused on developing antiviral therapies, oncology treatments, and other innovative medicines.
The takeaway
This investment by BCGM Wealth Management in Gilead Sciences reflects ongoing institutional interest in the biopharmaceutical company and its potential for future growth and innovation in the healthcare sector.
